“Does the dose of hydroxyurea correlate with shorter hospital stay and higher fetal hemoglobin levels in patients with sickle cell disease?”

Background & Aims Sickle cell disease (SCD) leads to recurrent vaso-occlusive crises (VOC) and hospitalizations, imposing a substantial healthcare burden. Hydroxyurea (HU) is known to reduce VOC frequency and hospitalization rates in SCD; however, data comparing the impact of different HU doses on l...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Musa Fares Alzahrani, Abdulaziz Albacker, Abdulmajeed Alshabanat, Maram Alharbi, Jawahir Abuhaimed, Nouran Arnous, Yara Alzahrani, Hind Aloraier, Maha Alamri, Rawan Altamimi, Ghazi Alotaibi, Sarah Sewaralthahab, Fatima Alshalti, Ibrahim Alrumaih, Ahmad Jamal, Farjah Algahtani, Aamer Aleem
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Taylor & Francis Group 2026-12-01
סדרה:	Future Science OA
נושאים:	Sickle cell disease sickle SCD hydroxyurea vaso-occlusive crisis
גישה מקוונת:	https://www.tandfonline.com/doi/10.1080/20565623.2025.2610223
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!